Phosphagenics to Host Investor Call on Wednesday, April 2nd at 4:00pm EDT (USA)
PR Newswire - Wed Mar 26, 7:00AM CDT
Phosphagenics Limited (ASX: POH) (OTCQX: PPGNY) ("Phosphagenics" or "the Company"
BioElixia(R) - Clinically Proven to Reduce the Appearance of Cellulite and Stretch Marks
PRWeb - Wed Nov 20, 2:44AM CST
BioElixia (R) : Unique in all BioElixia(R) products is world patented TPM(R) Dermal Delivery Technology, which delivers more key ingredients to where they are needed most. The proven TPM(R) technology was born in the Biotechnoical laboratories of the parent company Phosphagenics Ltd in Melborne, Australia and is the result of 14 years scientific research.
'Acne Vulgaris - Pipeline Review, H2 2013' Contains Discovery and Pre-Clinical Stage Products
M2 - Tue Sep 03, 10:10AM CDT
Research and Markets (http://www.researchandmarkets.com/research/mddqlt/acne_vulgaris) has announced the addition of the "Acne Vulgaris - Pipeline Review, H2 2013" report to their offering. Global Markets Direct's, 'Acne Vulgaris - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Acne Vulgaris, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Acne Vulgaris. Scope - A snapshot of the global therapeutic scenario for Acne Vulgaris. - A review of the Acne Vulgaris products under development by companies and universities/research institutes based on information derived from company and industry-specific sources. - Coverage of products based on various stages of development ranging from discovery till registration stages. - A feature on pipeline projects on the basis of monotherapy and combined therapeutics. - Coverage of the Acne Vulgaris pipeline on the basis of route of administration and molecule type. - Key discontinued pipeline projects. - Latest news and deals relating to the products. Companies Mentioned Normal 0 false false false MicrosoftInternetExplorer4 Advancell AndroScience Corporation AntiCancer, Inc. Ausio Pharmaceuticals, LLC Boehringer Ingelheim GmbH Braintree Laboratories, Inc. Ensoltek Co., Ltd. Foamix Ltd. Galderma S.A. Hygeia Therapeutics, Inc. Lee's Pharmaceutical Holdings Limited Maruho Co.,Ltd. Medicis Pharmaceutical Corporation NanoBio Corporation Phosphagenics Limited Photocure ASA Quest PharmaTech Inc. Toyama Chemical Co. Ltd Valeant Pharmaceuticals International XBiotech USA, Inc. XOMA Ltd. For more information visit http://www.researchandmarkets.com/research/md...ne_vulgari About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Phosphagenics Signs Research Agreement with the Agricultural Research Service
PR Newswire - Mon May 20, 7:00AM CDT
-- Collaboration with the U.S. Department of Agriculture's (USDA) Agricultural Research Service (ARS) in treatment of mastitis